Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Jett

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group studyK M Rowland, C L Loprinzi, E G Shaw, et al.
Cancer Research|July 17, 2001
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinomaS A Nicholson, N T Okby, M A Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancerW P Bennett, W S el-Deiry, W L Rush, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancerP D Bonomi, D Gandara, F R Hirsch, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group studyK M Rowland, C L Loprinzi, E G Shaw, et al.
Cancer Research|July 17, 2001
Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinomaS A Nicholson, N T Okby, M A Khan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancerW P Bennett, W S el-Deiry, W L Rush, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancerP D Bonomi, D Gandara, F R Hirsch, et al.
Pageof 8